Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
365 Results Found
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net
Flu hospitalization rate in 2024-25 highest in more than a decade
The flu hospitalization rate during the 2024-25 flu season was the highest since 2010-11, according to a report published Sept. 12 by the Centers for Disease Control and Prevention.
AHA responds to HHS RFI on deregulation
The AHA July 14 responded to a Department of Health and Human Services request for i
FDA recalls certain coaxial breathing sets, resuscitators, other products
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory syncytial virus this upcoming respiratory virus season compared to last year’s, according to its 2025-26 outlook released Aug. 25.
AHA podcast: HCA’s AI-Driven Patient Safety Evolution, Part 1
Randy Fagin, M.D., chief quality officer at HCA Healthcare, shares insights into the organization’s bold approach to improving safety outcomes.
AHA blog highlights Quest for Quality Prize, health systems leading in quality and safety
Read about the 2025 winner and finalist for the Quest for Quality Prize.
Reimagining health care: How two systems are leading the charge in quality and safety
Read about the 2025 Quest for Quality Prize winner and finalist — and apply for the 2026 award
Weather threats to drug production facilities examined in study
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster declaration was declared.
Study: Two-dose antibiotic may be as effective as IV therapy for serious staph infections
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating serious Staphylococcus aureus bloodstream infections.